Endava operates as a next-generation technology services provider with strong engineering capabilities and a history in digital transformation, especially in payments and financial services. Its medium-term outlook depends on becoming an "AI-native" partner that helps companies move artificial intelligence from pilot projects into production environments. The Dava.Flow methodology is tool-agnostic, agent-driven, and incorporates human oversight, allowing Endava to target higher-value, outcome-based work instead of standard outsourcing.
The company maintains long-standing client relationships, with a large portion of revenue recurring each year, supported by operations across roughly 32 countries. At the same time, it contends with competitive pressures, including a move away from time-and-materials contracts, tighter discretionary spending, and growing client concentration as it focuses on larger, multi-year deals. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Success will depend on whether the AI-focused pipeline can compensate for softness in traditional digital-transformation revenue.
Upcoming quarterly results will serve as important markers. Guidance for Q4 fiscal 2026 points to revenue of about £181–£185 million, and any signs of improving pipeline conversion, particularly in banking and capital markets, will draw attention. Progress on AI-native contracts, such as the NatWest Tyl collaboration and Mastercard work, could confirm the strategic shift if they translate into sustained higher-margin revenue.
Further expansion of partnerships with hyperscalers like OpenAI, Google Cloud, and AWS may generate additional demand as clients move beyond internal AI experiments. Capital allocation decisions also matter: Endava has been executing a share repurchase program that has increased borrowings, so investors will weigh buybacks against ongoing AI investments. Analyst views have grown more measured, with some firms issuing downgrades or reduced price targets in 2026, even as the overall consensus remains near Hold/Neutral.
Endava's performance is closely tied to enterprise spending on discretionary technology projects, which reacts to interest rates and inflation. Prolonged higher rates tend to lengthen sales cycles and postpone major commitments, directly affecting the pipeline. A steadier rate environment could help clients accelerate modernization and AI initiatives.
In its core payments vertical, Endava has seen multi-year revenue declines, so any recovery in financial-services technology budgets would provide support. Geopolitical and trade-policy uncertainties have also influenced client decisions, especially in areas like automotive. On the technology front, generative AI expands opportunities for AI-native services but risks commoditizing some traditional engineering work that clients or competitors might handle internally.
Looking ahead, Endava's trajectory hinges on whether the AI-native shift can restore revenue growth and support margin expansion. The company is intentionally moving from legacy digital-transformation contracts to outcome-based, fixed-price work powered by Dava.Flow, which management expects to improve delivery speed, economics, and client retention. Continued growth in AI-related revenue as a share of the total could help stabilize margins over time.
Beyond payments, expansion into healthcare, insurance, mobility, and the public sector—bolstered by partnerships with OpenAI and major cloud providers—offers a structural growth path. However, heavy spending on retraining, tooling, and hyperscaler ties has weighed on near-term profitability, and recent goodwill impairment along with negative free cash flow highlight execution risks. Competitive pressure from large IT services firms and internal enterprise teams, plus client concentration, remain key variables. Current analyst expectations reflect caution, with price targets lowered meaningfully in 2026, indicating that a sustained demand recovery will likely matter more than valuation alone for any lasting re-rating.
Tickeron's Trend Prediction Engine has become a regular part of my research workflow. This AI-powered tool helps assess whether a stock like EDVA may trend bullish, bearish, or sideways over the coming weeks or months. It provides searchable predictions, historical context, and alerts that complement fundamental analysis when tracking evolving conditions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for EDVA turned positive on October 06, 2026. Looking at past instances where EDVA's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EDVA's RSI Indicator exited the oversold zone, 42 of 49 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on EDVA as a result. In 64 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
Following a +5.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where EDVA advanced for three days, in 165 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for EDVA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.084) is normal, around the industry mean (3.482). P/E Ratio (-0.008) is within average values for comparable stocks, (-1.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (10.695) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating steady price growth. EDVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Biotechnology